Pages that link to "Q47864899"
Jump to navigation
Jump to search
The following pages link to Maximising multivalency effects in protein-carbohydrate interactions (Q47864899):
Displaying 50 items.
- A Glycopeptide Dendrimer Inhibitor of the Galactose-Specific Lectin LecA and of Pseudomonas aeruginosa Biofilms (Q27673963) (← links)
- Structure-based optimization of the terminal tripeptide in glycopeptide dendrimer inhibitors of Pseudomonas aeruginosa biofilms targeting LecA (Q27687825) (← links)
- Multivalency effects on Pseudomonas aeruginosa biofilm inhibition and dispersal by glycopeptide dendrimers targeting lectin LecA (Q27702214) (← links)
- Fucofullerenes as tight ligands of RSL and LecB, two bacterial lectins (Q30950389) (← links)
- Synthesis and solvodynamic diameter measurements of closely related mannodendrimers for the study of multivalent carbohydrate-protein interactions (Q34088664) (← links)
- Sugar-modified foldamers as conformationally defined and biologically distinct glycopeptide mimics (Q34205779) (← links)
- Rational design and synthesis of optimized glycoclusters for multivalent lectin-carbohydrate interactions: influence of the linker arm. (Q34226384) (← links)
- Glycopeptide dendrimers as Pseudomonas aeruginosa biofilm inhibitors (Q34570412) (← links)
- Selective targeting of dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN) with mannose-based glycomimetics: synthesis and interaction studies of bis(benzylamide) derivatives of a pseudomannobioside. (Q34589367) (← links)
- The multivalent effect in glycosidase inhibition: probing the influence of valency, peripheral ligand structure, and topology with cyclodextrin-based iminosugar click clusters. (Q34981135) (← links)
- 6-Azido hyacinthacine A2 gives a straightforward access to the first multivalent pyrrolizidine architectures (Q35204157) (← links)
- Multivalent glycoconjugates as anti-pathogenic agents (Q35444698) (← links)
- Synthesis of Carbohydrate Capped Silicon Nanoparticles and their Reduced Cytotoxicity, In Vivo Toxicity, and Cellular Uptake (Q35677032) (← links)
- Magnetic-optical nanohybrids for targeted detection, separation, and photothermal ablation of drug-resistant pathogens (Q35808674) (← links)
- Synthesis of heteroglycoclusters by using orthogonal chemoselective ligations (Q35889794) (← links)
- Expanding the library of divalent fucosidase inhibitors with polyamino and triazole-benzyl bridged bispyrrolidines (Q35932481) (← links)
- Affinity Enhancement by Ligand Clustering Effect Inspired by Peptide Dendrimers-Shank PDZ Proteins Interactions (Q35936842) (← links)
- Glycosylated gold nanoparticle libraries for label-free multiplexed lectin biosensing. (Q36012997) (← links)
- Designed ankyrin repeat proteins as scaffolds for multivalent recognition (Q36099748) (← links)
- Targeting the bacteria-host interface: strategies in anti-adhesion therapy (Q37009022) (← links)
- Harnessing glycomics technologies: Integrating structure with function for glycan characterization (Q37095486) (← links)
- Opportunities and challenges in synthetic oligosaccharide and glycoconjugate research (Q37477221) (← links)
- Tailored glycopolymers as anticoagulant heparin mimetics (Q37619706) (← links)
- Use of tetravalent galabiose for inhibition of streptococcus suis serotype 2 infection in a mouse model (Q37651483) (← links)
- Design and creativity in synthesis of multivalent neoglycoconjugates (Q37728426) (← links)
- Glyconanoparticles polyvalent tools to study carbohydrate-based interactions (Q37788384) (← links)
- Insights in the rational design of synthetic multivalent glycoconjugates as lectin ligands. (Q37822680) (← links)
- Thin‐Film‐Based Nanoarchitectures for Soft Matter: Controlled Assemblies into Two‐Dimensional Worlds (Q37867075) (← links)
- Self-assembled multivalency: dynamic ligand arrays for high-affinity binding (Q38017997) (← links)
- Multivalency in heterogeneous glycoenvironments: hetero-glycoclusters, -glycopolymers and -glycoassemblies. (Q38036582) (← links)
- Bacterial toxin inhibitors based on multivalent scaffolds (Q38069445) (← links)
- Multivalent glycoconjugate syntheses and applications using aromatic scaffolds (Q38080745) (← links)
- Bridging lectin binding sites by multivalent carbohydrates (Q38100083) (← links)
- The multivalent effect in glycosidase inhibition: a new, rapidly emerging topic in glycoscience (Q38210134) (← links)
- Multivalent glycosylated nanoparticles for studying carbohydrate-protein interactions (Q38222936) (← links)
- Multivalent inhibitors for carbohydrate-processing enzymes: beyond the "lock-and-key" concept (Q38235765) (← links)
- Tetra- versus Pentavalent Inhibitors of Cholera Toxin (Q38295903) (← links)
- Multivalent presentation of carbohydrates by 3(14)-helical peptide templates: synthesis, conformational analysis using CD spectroscopy and saccharide recognition. (Q38296277) (← links)
- Importance of topology for glycocluster binding to Pseudomonas aeruginosa and Burkholderia ambifaria bacterial lectins (Q38296311) (← links)
- Galectin Binding to Neo-Glycoproteins: LacDiNAc Conjugated BSA as Ligand for Human Galectin-3. (Q38297428) (← links)
- Synthesis of multivalent carbohydrate-centered glycoclusters as nanomolar ligands of the bacterial lectin LecA from Pseudomonas aeruginosa (Q38314886) (← links)
- Capture of uropathogenic E. coli by using synthetic glycan ligands specific for the pap-pilus. (Q38318624) (← links)
- Carbohydrate-PNA and aptamer-PNA conjugates for the spatial screening of lectins and lectin assemblies (Q38318782) (← links)
- Chiral self-assembly of lactose functionalized perylene bisimides as multivalent glycoclusters (Q38325858) (← links)
- Fluorophore-labeled, peptide-based glycoclusters: synthesis, binding properties for lectins, and detection of carbohydrate-binding proteins in cells (Q38334677) (← links)
- Supported Lipid Bilayers for the Generation of Dynamic Cell-Material Interfaces (Q38634937) (← links)
- Sequence and Architectural Control in Glycopolymer Synthesis. (Q38660455) (← links)
- The achievement of ligand-functionalized organic/polymeric nanoparticles for treating multidrug resistant cancer (Q38809044) (← links)
- Designing nanomolar antagonists of DC-SIGN-mediated HIV infection: ligand presentation using molecular rods (Q38913283) (← links)
- Inhibition of type 1 fimbriae-mediated Escherichia coli adhesion and biofilm formation by trimeric cluster thiomannosides conjugated to diamond nanoparticles. (Q38923171) (← links)